176 related articles for article (PubMed ID: 19631279)
1. Sialylation of Campylobacter jejuni lipo-oligosaccharides is associated with severe gastro-enteritis and reactive arthritis.
Mortensen NP; Kuijf ML; Ang CW; Schiellerup P; Krogfelt KA; Jacobs BC; van Belkum A; Endtz HP; Bergman MP
Microbes Infect; 2009 Oct; 11(12):988-94. PubMed ID: 19631279
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive analysis of bacterial risk factors for the development of Guillain-Barre syndrome after Campylobacter jejuni enteritis.
Koga M; Gilbert M; Takahashi M; Li J; Koike S; Hirata K; Yuki N
J Infect Dis; 2006 Feb; 193(4):547-55. PubMed ID: 16425134
[TBL] [Abstract][Full Text] [Related]
3. Sialylation of Campylobacter jejuni lipo-oligosaccharides: impact on phagocytosis and cytokine production in mice.
Huizinga R; Easton AS; Donachie AM; Guthrie J; van Rijs W; Heikema A; Boon L; Samsom JN; Jacobs BC; Willison HJ; Goodyear CS
PLoS One; 2012; 7(3):e34416. PubMed ID: 22470569
[TBL] [Abstract][Full Text] [Related]
4. Characterization of clinical Campylobacter jejuni isolates with special emphasis on lipooligosaccharide locus class, putative virulence factors and host response.
Ellström P; Feodoroff B; Hänninen ML; Rautelin H
Int J Med Microbiol; 2013 Apr; 303(3):134-9. PubMed ID: 23528202
[TBL] [Abstract][Full Text] [Related]
5. Multiple N-acetyl neuraminic acid synthetase (neuB) genes in Campylobacter jejuni: identification and characterization of the gene involved in sialylation of lipo-oligosaccharide.
Linton D; Karlyshev AV; Hitchen PG; Morris HR; Dell A; Gregson NA; Wren BW
Mol Microbiol; 2000 Mar; 35(5):1120-34. PubMed ID: 10712693
[TBL] [Abstract][Full Text] [Related]
6. Campylobacter jejuni capsular genotypes are related to Guillain-Barré syndrome.
Heikema AP; Islam Z; Horst-Kreft D; Huizinga R; Jacobs BC; Wagenaar JA; Poly F; Guerry P; van Belkum A; Parker CT; Endtz HP
Clin Microbiol Infect; 2015 Sep; 21(9):852.e1-9. PubMed ID: 26070960
[TBL] [Abstract][Full Text] [Related]
7. TLR4-mediated sensing of Campylobacter jejuni by dendritic cells is determined by sialylation.
Kuijf ML; Samsom JN; van Rijs W; Bax M; Huizinga R; Heikema AP; van Doorn PA; van Belkum A; van Kooyk Y; Burgers PC; Luider TM; Endtz HP; Nieuwenhuis EE; Jacobs BC
J Immunol; 2010 Jul; 185(1):748-55. PubMed ID: 20525894
[TBL] [Abstract][Full Text] [Related]
8. Comparative genomic analysis of Campylobacter jejuni associated with Guillain-Barré and Miller Fisher syndromes: neuropathogenic and enteritis-associated isolates can share high levels of genomic similarity.
Taboada EN; van Belkum A; Yuki N; Acedillo RR; Godschalk PC; Koga M; Endtz HP; Gilbert M; Nash JH
BMC Genomics; 2007 Oct; 8():359. PubMed ID: 17919333
[TBL] [Abstract][Full Text] [Related]
9. The sialylated lipooligosaccharide outer core in Campylobacter jejuni is an important determinant for epithelial cell invasion.
Louwen R; Heikema A; van Belkum A; Ott A; Gilbert M; Ang W; Endtz HP; Bergman MP; Nieuwenhuis EE
Infect Immun; 2008 Oct; 76(10):4431-8. PubMed ID: 18644887
[TBL] [Abstract][Full Text] [Related]
10. Mass spectrometric analysis of intact lipooligosaccharide: direct evidence for O-acetylated sialic acids and discovery of O-linked glycine expressed by Campylobacter jejuni.
Dzieciatkowska M; Brochu D; van Belkum A; Heikema AP; Yuki N; Houliston RS; Richards JC; Gilbert M; Li J
Biochemistry; 2007 Dec; 46(50):14704-14. PubMed ID: 18034462
[TBL] [Abstract][Full Text] [Related]
11. Relationship of bacterial strains to clinical syndromes of Campylobacter-associated neuropathies.
Kimoto K; Koga M; Odaka M; Hirata K; Takahashi M; Li J; Gilbert M; Yuki N
Neurology; 2006 Nov; 67(10):1837-43. PubMed ID: 17130419
[TBL] [Abstract][Full Text] [Related]
12. Multiple factors interact to produce responses resembling spectrum of human disease in Campylobacter jejuni infected C57BL/6 IL-10-/- mice.
Bell JA; St Charles JL; Murphy AJ; Rathinam VA; Plovanich-Jones AE; Stanley EL; Wolf JE; Gettings JR; Whittam TS; Mansfield LS
BMC Microbiol; 2009 Mar; 9():57. PubMed ID: 19296832
[TBL] [Abstract][Full Text] [Related]
13. C57BL/6 and congenic interleukin-10-deficient mice can serve as models of Campylobacter jejuni colonization and enteritis.
Mansfield LS; Bell JA; Wilson DL; Murphy AJ; Elsheikha HM; Rathinam VA; Fierro BR; Linz JE; Young VB
Infect Immun; 2007 Mar; 75(3):1099-115. PubMed ID: 17130251
[TBL] [Abstract][Full Text] [Related]
14. Genetic background of IL-10(-/-) mice alters host-pathogen interactions with Campylobacter jejuni and influences disease phenotype.
Mansfield LS; Patterson JS; Fierro BR; Murphy AJ; Rathinam VA; Kopper JJ; Barbu NI; Onifade TJ; Bell JA
Microb Pathog; 2008 Oct; 45(4):241-57. PubMed ID: 18586081
[TBL] [Abstract][Full Text] [Related]
15. Siglec-7 specifically recognizes Campylobacter jejuni strains associated with oculomotor weakness in Guillain-Barré syndrome and Miller Fisher syndrome.
Heikema AP; Jacobs BC; Horst-Kreft D; Huizinga R; Kuijf ML; Endtz HP; Samsom JN; van Wamel WJ
Clin Microbiol Infect; 2013 Feb; 19(2):E106-12. PubMed ID: 23173866
[TBL] [Abstract][Full Text] [Related]
16. Outcome of infection of C57BL/6 IL-10(-/-) mice with Campylobacter jejuni strains is correlated with genome content of open reading frames up- and down-regulated in vivo.
Bell JA; Jerome JP; Plovanich-Jones AE; Smith EJ; Gettings JR; Kim HY; Landgraf JR; Lefébure T; Kopper JJ; Rathinam VA; St Charles JL; Buffa BA; Brooks AP; Poe SA; Eaton KA; Stanhope MJ; Mansfield LS
Microb Pathog; 2013 Jan; 54():1-19. PubMed ID: 22960579
[TBL] [Abstract][Full Text] [Related]
17. Comparison of rheumatological and gastrointestinal symptoms after infection with Campylobacter jejuni/coli and enterotoxigenic Escherichia coli.
Locht H; Krogfelt KA
Ann Rheum Dis; 2002 May; 61(5):448-52. PubMed ID: 11959770
[TBL] [Abstract][Full Text] [Related]
18. Structural characterization of Campylobacter jejuni lipooligosaccharide outer cores associated with Guillain-Barre and Miller Fisher syndromes.
Godschalk PC; Kuijf ML; Li J; St Michael F; Ang CW; Jacobs BC; Karwaski MF; Brochu D; Moterassed A; Endtz HP; van Belkum A; Gilbert M
Infect Immun; 2007 Mar; 75(3):1245-54. PubMed ID: 17261613
[TBL] [Abstract][Full Text] [Related]
19. Antecedent infections in Fisher syndrome: a common pathogenesis of molecular mimicry.
Koga M; Gilbert M; Li J; Koike S; Takahashi M; Furukawa K; Hirata K; Yuki N
Neurology; 2005 May; 64(9):1605-11. PubMed ID: 15883324
[TBL] [Abstract][Full Text] [Related]
20. Campylobacter coli enteritis and Guillain-Barré syndrome: no evidence of molecular mimicry and serological relationship.
Funakoshi K; Koga M; Takahashi M; Hirata K; Yuki N
J Neurol Sci; 2006 Jul; 246(1-2):163-8. PubMed ID: 16600306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
